国产两女互慰高潮视频在线观看,无码人妻精品一二三区免费,亚洲av无码av制服另类专区,欧美一区二区三区成人片在线

首頁 > 產品目錄 > 信號通路 > Cell Cycle | 細胞周期 > CDK > (1R,3S)-3-(5-(3-(甲氧基甲基)-1-甲基-1H-吡唑-5-甲酰胺基)-1H-吡唑-3-基)環戊基異丙基氨基甲酸酯

(1R,3S)-3-(5-(3-(甲氧基甲基)-1-甲基-1H-吡唑-5-甲酰胺基)-1H-吡唑-3-基)環戊基異丙基氨基甲酸酯

ChemLeader 98+%

Tagtociclib (PF-07104091)

產品編號：CL1103 CAS No.：2460249-19-6 MDLNo： 分子式：C19H28N6O4 分子量：404.46
規格 庫存 目錄價 會員專享價 數量

暫無牌價信息，您可以發送詢價，我們會盡快給你回復。

化學品安全說明書(MSDS)

下載MSDS

質檢證書(COA)

  • 基本信息
  • 相關文檔
  • 產品詳情
  • 相關文獻
基本信息
英文名稱 Tagtociclib (PF-07104091)
中文名稱(1R,3S)-3-(5-(3-(甲氧基甲基)-1-甲基-1H-吡唑-5-甲酰胺基)-1H-吡唑-3-基)環戊基異丙基氨基甲酸酯
CAS號2460249-19-6
分子式C19H28N6O4
分子量404.46
外觀Solid powder
儲存條件Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
產品詳情

Tagtociclib, also known as PF-07104091, is an orally bioavailable inhibitor of cyclin-dependent kinase 2 (CDK2), with potential antineoplastic activity. Upon administration, CDK2 inhibitor PF-07104091 selectively targets, binds to and inhibits the activity of CDK2. This may lead to cell cycle arrest, the induction of apoptosis, and the inhibition of tumor cell proliferation. CDKs are serine/threonine kinases that are important regulators of cell cycle progression and cellular proliferation and are frequently overexpressed in tumor cells. CDK2/cyclin E complex plays an important role in retinoblastoma (Rb) protein phosphorylation and the G1-S phase cell cycle transition. CDK2/cyclin A complex plays an important role in DNA synthesis in S phase and the activation of CDK1/cyclin B for the G2-M phase cell cycle transition.

相關文獻
抱歉，暫時沒有相關文獻
相關產品
抱歉，暫時沒有相關產品
在線客服
小德
021-58180488
小立
021-58180488
在線服務時間: 工作日 9:00-18:00